The most serious gadolinium side effect is nephrogenic
systemic fibrosis / nephrogenic fibrosing dermopathy (NSF / NFD), a scarring condition that can lead to total gadolinium kidney failure.
Some patients with kidney disease have had gadolinium reactions leading to a potentially fatal condition called nephrogenic
systemic fibrosis (NSF), also known as nephrogenic fibrosing dermopathy (NFD), which can lead to gadolinium renal failure.
Nephrogenic
systemic fibrosis (NSF) is just one of many types of fibrosis, or scarring, that can affect the connective tissues of the body.
The first alarm came from the discovery that Nephrogenic
Systemic Fibrosis (NSF) was linked to the administration of Gd - CAs.
But while the gadolinium - based agents have become the standard, evidence shows that in some very rare cases they can lead to an untreatable condition called nephrogenic
systemic fibrosis, which can be fatal.
To date, the only known disease related to gadolinium injections is nephrogenic
systemic fibrosis, a condition only occurring in a tiny subgroup of patients with renal failure.
Certain linear GBCAs have previously been linked to a rare but serious disease (called nephrogenic
systemic fibrosis) in patients with severely impaired kidney function.
Not exact matches
Common liver diseases in dogs include infectious canine hepatitis, chronic active hepatitis, Porto -
systemic shunt, hepatic microvascular dysplasia, liver
fibrosis, copper toxicosis and cancer.